Page last updated: 2024-11-10

tectoridin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

tectoridin: glycosylated tectorigenin [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

tectoridin : A glycosyloxyisoflavone that is tectorigenin substituted by a beta-D-glucopyranosyl residue at position 7 via a glycosidic linkage. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID5281810
CHEMBL ID520214
CHEBI ID9428
SCHEMBL ID241734
MeSH IDM0307113

Synonyms (37)

Synonym
4h-1-benzopyran-4-one, 7-(beta-d-glucopyranosyloxy)-5-hydroxy-3-(4-hydroxyphenyl)-6-methoxy-
brn 0068384
tectoridin (7ci,8ci)
4',5-dihydro-6-methoxy-7-(o-glucoside)isoflavone
611-40-5
shekanin
tectoridin
CHEMBL520214
chebi:9428 ,
5-hydroxy-3-(4-hydroxyphenyl)-6-methoxy-7-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one
968x515nzh ,
4-18-00-03312 (beilstein handbook reference)
unii-968x515nzh
AKOS015897164
SCHEMBL241734
tectoridin [mi]
4h-1-benzopyran-4-one, 7-(.beta.-d-glucopyranosyloxy)-5-hydroxy-3-(4-hydroxyphenyl)-6-methoxy-
tectorigenin-7-glucoside
tectorigenin 7-o-.beta.-d-glucopyranoside
T3724
5-hydroxy-3-(4-hydroxyphenyl)-6-methoxy-7-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-chromen-4-one
5-hydroxy-3-(4-hydroxyphenyl)-6-methoxy-4-oxo-4h-1-benzopyran-7-yl beta-d-glucopyranoside
Q-100704
CNOURESJATUGPN-UDEBZQQRSA-N
DTXSID70209982
mfcd01662715
7-(beta-d-glucopyranosyloxy)-5-hydroxy-3-(4-hydroxyphenyl)-6-methoxy-4h-1-benzopyran-4-one
5-hydroxy-3-(4-hydroxyphenyl)-6-methoxy-7-(((2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2h-pyran-2-yl)oxy)-4h-chromen-4-one
HY-N0791
BS-17204
Q10860610
CCG-269367
CS-0009803
S3818
bdbm50540975
A868796
tectorigenin 7-o-beta-d-glucopyranoside

Research Excerpts

Overview

Tectoridin is a botanical active ingredient with anti-inflammatory properties. It is found in the flowers of Pueraria thomsonii Benth.

ExcerptReferenceRelevance
"Tectoridin is a botanical active ingredient with anti-inflammatory properties."( Tectoridin exhibits anti-rheumatoid arthritis activity through the inhibition of the inflammatory response and the MAPK pathway in vivo and in vitro.
Han, T; Huang, Q; Li, W; Liu, Y; Niu, X; Song, H; Xiao, X; Yang, Y; Yu, J; Zhang, D, 2022
)
2.89
"Tectoridin is a major isoflavone found in the flowers of Pueraria thomsonii Benth. "( Pharmacokinetics of conjugated metabolites in rat plasma after oral administration of tectoridin.
Gao, J; Makino, T; Qu, J; Sun, J; Yuan, D; Zhang, L, 2012
)
2.04

Treatment

ExcerptReferenceRelevance
"Tectoridin treatment further suppressed actin ring formation and in vitro bone resorption as determined via F-actin staining and scanning electron microscopy."( Tectoridin inhibits osteoclastogenesis and bone loss in a murine model of ovariectomy-induced osteoporosis.
Bao, Y; Lv, X; Ma, B; Tang, Y; Wang, G; Wang, J; Wen, X; Zhang, J, 2020
)
2.72

Pharmacokinetics

The present method was successfully applied to the pharmacokinetic studies of tectoridin in rats after intravenous administration of three different doses. This study was aimed to analyze the Pharmacokinetic profile of Tectorigenin (the metabolite of tctoridin) after oral administration of I.

ExcerptReferenceRelevance
" The present method was successfully applied to the pharmacokinetic studies of tectoridin in rats after intravenous administration of three different doses."( Determination of tectoridin in rat plasma by high-performance liquid chromatography and its application to pharmacokinetic studies.
Chen, Z; Guo, Y; Jiang, X; Liu, T; Ma, G, 2009
)
0.92
" In the present study, we evaluated the plasma pharmacokinetic profile of tectoridin in rats."( Pharmacokinetics of conjugated metabolites in rat plasma after oral administration of tectoridin.
Gao, J; Makino, T; Qu, J; Sun, J; Yuan, D; Zhang, L, 2012
)
0.83

Dosage Studied

ExcerptRelevanceReference
" at the same dosage for 10 days to ICR mice bearing sarcoma 180, caused a significant suppression in tumor weight by 44."( Anti-angiogenic and anti-tumor activities of isoflavonoids from the rhizomes of Belamcanda chinensis.
Jung, SH; Kim, YS; Lee, S; Lee, YS; Lim, SS; Ohuchi, K; Shin, KH, 2003
)
0.32
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
plant metaboliteAny eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (4)

ClassDescription
hydroxyisoflavoneMember of the class of isoflavones bearing at least one hydroxy group.
methoxyisoflavoneMembers of the class of isoflavones with at least one methoxy substituent.
monosaccharide derivativeA carbohydrate derivative that is formally obtained from a monosaccharide.
7-hydroxyisoflavones 7-O-beta-D-glucosideA glycosyloxyisoflavone that is any 7-hydroxyisoflavone compound in which the 7-hydroxy group has been converted into its corresponding O-beta-D-glucoside.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (7)

Assay IDTitleYearJournalArticle
AID377455Estrogenic activity in human MCF7 cells assessed as drug level causing stimulation of cell proliferation equivalent to 10 pM estradiol by alamar blue assay2005Journal of natural products, Mar, Volume: 68, Issue:3
Phenolic constituents of the rhizomes of the Thai medicinal plant Belamcanda chinensis with proliferative activity for two breast cancer cell lines.
AID338974Inhibition of cow milk xanthine oxidase at 50 ug/mL
AID377457Estrogenic activity in human T47D cells assessed as drug level causing stimulation of cell proliferation equivalent to 10 pM estradiol by alamar blue assay2005Journal of natural products, Mar, Volume: 68, Issue:3
Phenolic constituents of the rhizomes of the Thai medicinal plant Belamcanda chinensis with proliferative activity for two breast cancer cell lines.
AID477213Increase in insulin-stimulated [3H]2-deoxy-D-glucose uptake in mouse 3T3L1cells at 1 uM after 3 days by liquid scintillation counting relative to insulin2010Journal of natural products, Apr-23, Volume: 73, Issue:4
Homoisoflavonoids from the fibrous roots of Polygonatum odoratum with glucose uptake-stimulatory activity in 3T3-L1 adipocytes.
AID1656436Inhibition of beta-glucuronidase (unknown origin)2020European journal of medicinal chemistry, Feb-01, Volume: 187Therapeutic significance of β-glucuronidase activity and its inhibitors: A review.
AID377456Estrogenic activity in human MCF7 cells assessed as drug level causing stimulation of cell proliferation equivalent to 100 pM estradiol by alamar blue assay2005Journal of natural products, Mar, Volume: 68, Issue:3
Phenolic constituents of the rhizomes of the Thai medicinal plant Belamcanda chinensis with proliferative activity for two breast cancer cell lines.
AID377458Estrogenic activity in human T47D cells assessed as drug level causing stimulation of cell proliferation equivalent to 100 pM estradiol by alamar blue assay2005Journal of natural products, Mar, Volume: 68, Issue:3
Phenolic constituents of the rhizomes of the Thai medicinal plant Belamcanda chinensis with proliferative activity for two breast cancer cell lines.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (46)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's4 (8.70)18.2507
2000's17 (36.96)29.6817
2010's16 (34.78)24.3611
2020's9 (19.57)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 24.46

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index24.46 (24.57)
Research Supply Index3.87 (2.92)
Research Growth Index5.00 (4.65)
Search Engine Demand Index26.67 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (24.46)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (2.13%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other46 (97.87%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]